Intraventricular thrombolysis speeds blood clot resolution: Results of a pilot, prospective, randomized, double-blind, controlled trial

Neurosurgery

Volumn 54, Issue 3, 2004, Pages 577-584

  Naff, Neal J ^a,f   Hanley, Daniel F ^a   Keyl, Penelope M ^a   Tuhrim, Stanley ^b   Kraut, Michael ^a   Bederson, Joshua ^b   Bullock, Ross ^c   Mayer, Stephan A ^d   Schmutzhard, Eric ^e   Selman, Warren R ^g   Chandler, William F ^g   Garton, Hugh ^g   Chittum, Christopher J ^g   Haines, Stephen J ^g   Findlay, J Max ^g   Grossman, Robert G ^g  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d New York Presbyterian Hospital Columbia University Medical Center   (United States)

^e UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^f Sinai Medical Office Building   (United States)

^g NONE

Author keywords

Cerebrospinal fluid; External ventricular drainage; Intracerebral hemorrhage; Intraventricular hemorrhage; Thrombolysis; Urokinase

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; PLACEBO; PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ANIMAL MODEL; ARTICLE; BACTEREMIA; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN VENTRICULITIS; CEREBROSPINAL FLUID SHUNTING; CLINICAL ARTICLE; CLINICAL TRIAL; COMMUNICATING HYDROCEPHALUS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; MULTICENTER STUDY; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 10744226227     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000108422.10842.60     Document Type: Article

References (32)

1. Akdemir H, Selcuklu A, Pasaoglu A, Oktem IS, Kavuncu I: Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg Rev 18:95-100, 1995.
2. Coplin WM, Vinas FC, Agris JM, Buciuc R, Michael DB, Diaz FG, Muizelaar JP: A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke 29: 1573-1579, 1998.
3. Daverat P, Castel JP, Dartigues JF, Orgogozo JM: Death and functional outcome after spontaneous intracerebral hemorrhage: A prospective study of 166 cases using multivariate analysis. Stroke 22:1-6, 1991.
4. Dawson-Saunders EK, Trapp RG: Basic and Clinical Biostatistics. Norwalk, Appleton & Lange, 1994, ed 2.
5. Falcó C, Tormo G, Estellés A, España F, Tormo E, Gilabert J, Velasco JA, Aznar J: Fibrinolysis and lipoprotein(a) in women with coronary artery disease: Influence of hormone replacement therapy. Haematologica 86:92-98, 2001.
6. Fang J, Alderman MH: Trend of stroke hospitalization, United States, 1988-1997. Stroke 32:2221-2226, 2001.
7. Findlay JM, Grace MG, Weir BK: Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery 32:941-947, 1993.
8. Findlay JM, Weir BK, Stollery DE: Lysis of intraventricular hematoma with tissue plasminogen activator: Case report. J Neurosurg 74:803-807, 1991.
9. Goh KY, Poon WS: Recombinant tissue plasminogen activator for the treatment of spontaneous adult intraventricular hemorrhage. Surg Neurol 50: 526-532, 1998.
10. Grabb PA: Traumatic intraventricular hemorrhage treated with intraventricular recombinant tissue plasminogen activator: Technical case report. Neurosurgery 43:966-969, 1998.
11. Haines SJ, Lapointe M: Fibrinolytic agents in the treatment of intraventricular hemorrhage in adults. Crit Rev Neurosurg 8:169-175, 1998.
12. Hansen AR, Volpe JJ, Goumnerova LC, Madsen JR: Intraventricular urokinase for the treatment of posthemorrhagic hydrocephalus. Pediatr Neurol 17:213-217, 1997.
13. Hudgins RJ, Boydston WR, Hudgins PA, Adler SR: Treatment of intraventricular hemorrhage in the premature infant with urokinase: A preliminary report. Pediatr Neurosurg 20:190-197, 1994.
14. Hudgins RJ, Boydston WR, Hudgins PA, Morris R, Adler SM, Gilreath CL: Intrathecal urokinase as a treatment for intraventricular hemorrhage in the preterm infant. Pediatr Neurosurg 26:281-287, 1997.
15. Mayfrank L, Hutter BO, Kohorst Y, Kreitschmann-Andermahr I, Rohde V, Thron A, Gilsbach JM: Influence of intraventricular hemorrhage on outcome after rupture of intracranial aneurysm. Neurosurg Rev 24:185-191, 2001.
16. Mayfrank L, Kissler J, Raoofi R, Delsing P, Weis J, Kuker W, Gilsbach JM: Ventricular dilatation in experimental intraventricular hemorrhage in pigs: Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment. Stroke 28:141-148, 1997.
17. Mayfrank L, Lippitz B, Groth M, Bertalanffy H, Gilsbach JM: Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta Neurochir (Wien) 122:32-38, 1993.
18. Mayfrank L, Rohde V, Gilsbach JM: Fibrinolytic treatment of intraventricular haemorrhage preceding surgical repair of ruptured aneurysms and arteriovenous malformations. Br J Neurosurg 13:128-131, 1999.
19. Murry KR, Rhoney DH, Coplin WM: Urokinase in the treatment of intraventricular hemorrhage. Ann Pharmacother 32:256-258, 1998.
20. Naff NJ, Carhuapoma JR, Williams MA, Bhardwaj A, Ulatowski JA, Bederson J, Bullock R, Schmutzhard E, Pfausler B, Keyl PM, Tuhrim S, Hanley DF: Treatment of intraventricular hemorrhage with urokinase: Effects on 30-day survival. Stroke 31:841-847, 2000.
21. Naff NJ, Williams MA, Rigamonti D, Keyl PM, Hanley DF: Blood clot resolution in human cerebrospinal fluid: Evidence of first-order kinetics. Neurosurgery 49:614-621, 2001.
22. Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A: Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: A systematic review of the literature. J Neurol 247:117-121, 2000.
23. Pang D, Sclabassi RJ, Horton JA: Lysis of intraventricular blood clot with urokinase in a canine model: Part 3-Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery 19:553-572,1986.
24. Rainov NG, Burkert WL: Urokinase infusion for severe intraventricular haemorrhage. Acta Neurochir (Wien) 134:55-59, 1995.
25. Rhoney DH, Coplin WM, Zaran FK, Brish LK, Weingarten CM: Urokinase activity after freezing: Implications for thrombolysis in intraventricular hemorrhage. Am J Health Syst Pharm 56:2047-2051, 1999.
26. Schwarz S, Schwab S, Steiner HH, Hacke W: Secondary hemorrhage after intraventricular fibrinolysis: A cautionary note-A report of two cases. Neurosurgery 42:659-663, 1998.
27. Schwarz S, Schwab S, Steiner HH, Hanley D, Hacke W: Fibrinolysis of intraventricular hematoma with rt-PA [in German]. Nervenarzt 70:123-130, 1999.
28. Shen PH, Matsuoka Y, Kawajiri K, Kanai M, Hoda K, Yamamoto S, Nishimura S: Treatment of intraventricular hemorrhage using urokinase. Neurol Med Chir (Tokyo) 30:329-333, 1990.
29. Steiner L, Bergvall U, Zwetnow N: Quantitative estimation of intracerebral and intraventricular hematoma by computer tomography. Acta Radiol Suppl 346:143-154, 1975.
30. Todo T, Usui M, Takakura K: Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurg 74:81-86, 1991.
31. Tuhrim S, Horowitz DR, Sacher M, Godbold JH: Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 27:617-621, 1999.
32. Tung MY, Ong PL, Seow WT, Tan KK: A study on the efficacy of intraventricular urokinase in the treatment of intraventricular haemorrhage. Br J Neurosurg 12:234-239, 1998.